RxDoctor Payments Data

Frederick Dorroh, MD

Surgery · Ardmore, OKNPI 1275511214

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.5%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 71.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $5,266 and has fallen 65.6% since, to $1,812 in 2025. Among surgery clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,762in general payments, 2019–2025

Across 96 payments — averaging $195.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$13K
  • Enterra Medical, Inc.$2K
  • TELA Bio, Inc.$1K
  • Davol Inc.$948
  • Endogastric Solutions, Inc$377
  • TAS Medical, Inc.$181
  • plus $745 from 16 others

What the payments were for

  • Travel & lodging$6,66936%
  • Food & beverage$4,08322%
  • Education$5,00027%
  • Gifts$90%
  • Other$3,00016%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,762 in reported general payments places this provider in the 90th percentile of 290 surgery providers in Oklahoma.

See all surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$135,697
Medicare patients
398
Services billed
809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SutabSod Sulf/Pot Chloride/Mag Sulf73$11,787
Pantoprazole Sodium232$3,664
Omeprazole74$1,329
Colestipol Hcl12$1,093
Sucralfate47$1,051
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen70$490
Esomeprazole Magnesium12$377
Doxycycline Hyclate16$338
Metoclopramide Hcl19$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Braintree Laboratories, Inc.Sutab$13$11,78773 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 290 surgery providers in Oklahoma.

Other surgery in Ardmore

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →